Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
13F holders, Q2 2023
Institutional positions in Silence Therapeutics plc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- 0 vs. Q1 2023
- Shares held
- 19.2M
- +831.7K (+4.5%) vs. Q1 2023
- Total value
- $101.8M
- −$8.45M (−7.7%) vs. Q1 2023
- New holders
- 2
- 12 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $236.2M |
| Q1 2026 | 56 | $102.1M |
| Q4 2025 | 58 | $106.1M |
| Q3 2025 | 54 | $96.4M |
| Q2 2025 | 55 | $108.0M |
| Q1 2025 | 59 | $60.6M |
| Q4 2024 | 65 | $168.2M |
| Q3 2024 | 69 | $493.1M |
| Q2 2024 | 71 | $502.1M |
| Q1 2024 | 64 | $588.0M |
| Q4 2023 | 34 | $343.9M |
| Q3 2023 | 28 | $187.6M |
| Q2 2023 | 29 | $101.8M |
| Q1 2023 | 29 | $110.2M |
| Q4 2022 | 27 | $275.7M |
| Q3 2022 | 29 | $183.4M |
| Q2 2022 | 25 | $116.4M |
| Q1 2022 | 26 | $218.3M |
| Q4 2021 | 22 | $246.6M |
| Q3 2021 | 7 | $39.4M |
| Q2 2021 | 6 | $56.4M |
| Q1 2021 | 6 | $55.9M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Silence Therapeutics plc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lombard Odier Asset Management (Europe) Ltd | 3,415,360 | $18.8M | 0.90% | +121,955+3.7% | Added |
| Lombard Odier Asset Management (USA) Corp | 4,120,416 | $18.7M | 2.09% | +161,315+4.1% | Added |
| TCG Crossover Management, LLC | 2,104,875 | $11.6M | 1.90% | 00.0% | Unchanged |
| Deep Track Capital, LP | 1,951,580 | $10.7M | 0.50% | 00.0% | Unchanged |
| Artal Group S.A. | 1,700,000 | $9.35M | 0.30% | +1,194,926+236.6% | Added |
| BVF Inc | 1,508,416 | $8.30M | 0.23% | 00.0% | Unchanged |
| Aquilo Capital Management, LLC | 1,312,233 | $7.22M | 4.74% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 881,173 | $4.85M | 0.29% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 410,000 | $2.25M | 0.00% | −250,000−37.9% | Reduced |
| M28 Capital Management LP | 363,800 | $2.00M | 2.64% | +217,900+149.3% | Added |
| Cantor Fitzgerald, L. P. | 293,893 | $1.62M | 0.04% | +4,735+1.6% | Added |
| Woodline Partners LP | 239,360 | $1.32M | 0.02% | +95,676+66.6% | Added |
| Parkman Healthcare Partners LLC | 185,078 | $1.02M | 0.18% | +26,304+16.6% | Added |
| HSBC Holdings PLC | 177,834 | $988.8K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 98,326 | $540.8K | 0.01% | +2,943+3.1% | Added |
| Point72 Asset Management, L.P. | 86,700 | $476.9K | 0.00% | −262,762−75.2% | Reduced |
| UBS Group AG | 70,130 | $385.7K | 0.00% | +1,124+1.6% | Added |
| Morgan Stanley | 65,606 | $360.8K | 0.00% | −7,071−9.7% | Reduced |
| AXA S.A. | 58,624 | $322.4K | 0.00% | −457,792−88.6% | Reduced |
| Citigroup Inc | 58,333 | $320.8K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 47,000 | $258.5K | 0.00% | +5,900+14.4% | Added |
| Blair William & Co | 38,986 | $214.4K | 0.00% | −2,277−5.5% | Reduced |
| Millennium Management LLC | 22,832 | $125.6K | 0.00% | +3,148+16.0% | Added |
| Geode Capital Management, LLC | 17,207 | $94.6K | 0.00% | +2,520+17.2% | Added |
| Tower Research Capital LLC (TRC) | 800 | $4.40K | 0.00% | +800 | New |
| Deutsche Bank AG | 620 | $3.41K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 550 | $3.02K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 100 | $550 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 5 | $27 | 0.00% | +5 | New |
| WS Management LLLP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −2,600−100.0% | Sold out |